BAVIERA, Giovanni
 Distribuzione geografica
Continente #
NA - Nord America 1.060
EU - Europa 882
AS - Asia 197
OC - Oceania 3
Totale 2.142
Nazione #
US - Stati Uniti d'America 1.057
SE - Svezia 277
IE - Irlanda 266
CN - Cina 157
UA - Ucraina 124
DE - Germania 77
FI - Finlandia 45
IT - Italia 28
GB - Regno Unito 23
SG - Singapore 21
BE - Belgio 19
IN - India 15
FR - Francia 13
IR - Iran 4
CA - Canada 3
NL - Olanda 3
RU - Federazione Russa 3
NZ - Nuova Zelanda 2
AU - Australia 1
HR - Croazia 1
LU - Lussemburgo 1
PT - Portogallo 1
RO - Romania 1
Totale 2.142
Città #
Dublin 265
Jacksonville 232
Chandler 195
Nyköping 145
Beijing 61
Ann Arbor 57
Boardman 49
Cambridge 42
Princeton 42
Ashburn 40
Medford 33
Dearborn 32
Des Moines 31
Woodbridge 28
Brussels 19
Singapore 16
Jinan 15
Shenyang 14
Los Angeles 11
Wilmington 10
Ningbo 8
San Mateo 8
Zhengzhou 8
Houston 7
Pune 6
Catania 5
Hangzhou 5
Hebei 5
New York 5
Taizhou 5
Washington 5
Ardabil 4
Haikou 4
Hyderabad 4
Nanjing 4
Tianjin 4
Bremen 3
Helsinki 3
Jiaxing 3
Messina 3
Mumbai 3
Nanchang 3
Auburn Hills 2
Chicago 2
Fuzhou 2
Lancaster 2
Lanzhou 2
Milan 2
Mountain View 2
Norwalk 2
Rome 2
Viagrande 2
Akron 1
Andover 1
Asti 1
Auckland 1
Bangalore 1
Brasov 1
Cagliari 1
Changsha 1
Cosenza 1
Frankfurt am Main 1
Guangzhou 1
Gurgaon 1
Hefei 1
Jeffries 1
Jinhua 1
Langfang 1
Lisbon 1
Lucan 1
Luxembourg 1
Modena 1
Monmouth Junction 1
Montreal 1
Palermo 1
Pomezia 1
Reno 1
Seattle 1
Taiyuan 1
Tomsk 1
Toronto 1
Vancouver 1
Xian 1
Zagreb 1
Totale 1.494
Nome #
ADAM 12 and PAPP-A at 14–17 weeks' gestation as biomarkers of pre-eclampsia. 85
Tissue transglutaminase autoantibody determination in coeliac disease 72
Plasma homocysteine in early and late pregnancies complicated with preeclampsia and isolated intrauterine growth restriction 72
First trimester serum PAPP-A and NGAL in the prediction of late-onset pre-eclampsia. 71
Adiponectin and insulin resistance in early- and late-onset pre-eclampsia 67
ICAM-1 in maternal serum and amniotic fluid as an early marker of preeclampsia and IUGR 66
The clinical utility of serum uric acid measurements in pre- eclampsia and transient hypertension in pregnancy 64
First trimester free-beta-hCG and beta-core-hCG in maternal urine. 64
Neutrophil gelatinase-associated lipocalin serum evaluation through normal pregnancy and in pregnancies complicated by preeclampsia. 63
Plasma adiponectin concentration in early pregnancy and subsequent risk of hypertensive disorders 62
First trimester serum neutrophil gelatinase-associated lipocalin in gestational diabetes 61
Effects of the phytoestrogen genistein on hot flushes, endometrium, and vaginal epithelium in postmenopausal women: a 1-year randomized, double-blind, placebo-controlled study 59
Prostate-specific antigen in prenatal screening for Down's syndrome 58
Midtrimester amniotic fluid adiponectin in normal pregnancy. 56
Neurokinin B peptide levels in normal pregnancy 53
C-reactive protein as an early predictor of gestational diabetes mellitus 53
Variazioni del pattern ormonale ipofisario e steroideo durante il periodo post-operatorio precoce in donne sottoposte a castrazione chirurgica 53
Is mid-trimester maternal serum inhibin-A a marker of preeclampsia or intrauterine growth restriction? 52
Endocrine changes in postmenopausal women after high-dose danazol therapy 52
Endoglin, PlGF and sFlt-1 as markers for predicting pre-eclampsia. 52
Midtrimester Amniotic Fluid Leptin and Insulin Levels and Subsequent Gestational Diabetes. 50
Prostate specific antigen in amniotic fluid and maternal serum 49
Effects of the phytoestrogen genistein on hot flushes, endometrium and vaginal epithelium in postmenopausal women: a 2-year randomized, double-blind, placebo-controlled study 49
First- and Second-Trimester ADAM12s in Down Syndrome Screening. 49
Maternal serum PAPP-A as an early marker of obstetric complications? 49
First trimester serum PAPP-A and NGAL in the prediction of late-onset preeclampsia 47
Neurokinin B and nitric oxide plasma levels in pre-eclampsia and isolated intrauterine growth restriction 46
The placental growth hormone in Down's syndrome screening 46
Second trimester amniotic fluid myo-inositol concentrations in women later developing gestational diabetes mellitus or pregnancy-induced hypertension 46
Second trimester neutrophil gelatinase-associated lipocalin as a potential prediagnostic marker of preeclampsia. 42
Myo-inositol in Down syndrome amniotic fluid. A case-control study. 42
First trimester free-beta-hCG in maternal serum and urine as a Down syndrome marker. 42
Riserva funzionale di prolattina e TSH dopo stimolazione acuta con TRH e domperidone in donne affette da mastopatia fibrocistica 40
L’endoglina come fattore predittivo della preeclampsia. 40
Serum Ca-125 levels in aneuploidy screening in first pregnancy trimester. 39
Prolactin(PRL) levels during ovulation induction with purified urinary follicle stimulating hormone(FSH) and human menopausal gonadotrophin(HMG) 39
Fattori antiangiogenici e preeclampsia 38
The effect of the phytoestrogen genistein and hormone replacement therapy on homocysteine and C-reactive protein level in postmenopausal women. 37
Preliminary study on hormonal response to recombinant bovine GH (rbGH) in pregnnt ewe. 37
Prolactin (PRL) levels during ovulation induction with purified urinary follicle stimulating hormone (FSH)and human menopausal gonadotropin(hMG). 36
Pituitary testicular axis function and sex hormonebinding globulin binding capacity in thalassaemia major 30
PlGF e sFlt-1 quali markers precoci della preeclampsia. 28
Totale 2.156
Categoria #
all - tutte 8.523
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 8.523


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020304 0 30 3 31 1 36 45 43 15 38 58 4
2020/2021264 39 1 67 12 8 36 3 30 0 36 21 11
2021/2022313 3 41 5 9 12 1 32 12 5 82 34 77
2022/2023812 57 72 47 50 68 89 5 54 330 2 34 4
2023/2024167 16 28 6 23 17 23 9 1 0 6 1 37
2024/202517 9 8 0 0 0 0 0 0 0 0 0 0
Totale 2.156